Here are a couple of posts which explain it all. Please note that the stock I was trying to trade was NOT the same stock that I was attempting to get certificates for....
November 14th 2002 ( two SI posts)
Ameritrade are refusing to trade Genemax (GMXX) stock. I cannot enter new buy orders or sell the stock I have in my account long. It is shown in my account with zero value even though it is actually trading (last sale $18.20).
This is scandalous. I am blocked from selling my stock if and when I wish to. Who is liable if the stock drops and I am not even allowed to place an order to sell?
Ameritrade and GMXX.
I had no trouble buying and selling up until today. For some reason it was "removed from the data base" sometime today and wasn't replaced for several hours. Even then I could sell but a buy order while accepted normally and which was marketable for over 15 minutes was eventually marked as "Cancelled" and I didn't cancel it. This apparently has happened to others.
This coincided with a huge run down of the stock by the MMs on very low volume. It is the Brokers and MMs who are naked short this stock and can't deliver and right at the critical time Ameritrade blocks all the buyers and marketable buy orders are cancelled by them while sell orders go through normally.
A very fortunate coincidence for the MMs don't you think!
Recent MRKR News
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 02/04/2025 09:05:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 02/04/2025 09:05:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/30/2025 09:05:26 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 01/21/2025 05:15:11 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/17/2025 09:13:02 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 01/13/2025 09:05:17 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 01/10/2025 10:09:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/26/2024 09:01:17 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/23/2024 09:40:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/23/2024 09:30:19 PM
- Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 12/23/2024 09:30:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/19/2024 01:21:17 PM
- Marker Therapeutics Announces $16.1 Million Private Placement • GlobeNewswire Inc. • 12/19/2024 01:06:43 PM
- Marker Therapeutics Provides a Clinical Update on MT-601 in Patients with Lymphoma • GlobeNewswire Inc. • 12/19/2024 01:05:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/17/2024 12:10:42 PM
- Marker Therapeutics Awarded $9.5 Million Grant from the Cancer Prevention & Research Institute of Texas (CPRIT) to Support the Investigation of MT-601 in Patients with Pancreatic Cancer • GlobeNewswire Inc. • 12/17/2024 12:00:19 PM
- Marker Therapeutics to Present at the 2024 Ladenburg Thalmann & Co. Virtual Oncology Innovators and Investors Symposium • GlobeNewswire Inc. • 12/10/2024 01:30:44 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 12/06/2024 09:30:26 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 11/27/2024 09:27:23 PM
- Marker Therapeutics to Present at the Citizens JMP Hematology and Oncology Summit • GlobeNewswire Inc. • 11/26/2024 04:00:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/14/2024 09:45:17 PM
- Marker Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Updates • GlobeNewswire Inc. • 11/14/2024 09:30:25 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2024 09:05:42 PM
UAV Corp. Expanding in the Global UAV Market, Projected to Exceed $58 Billion by 2027, with Increasing Government and Commercial Sector Adoption • UMAV • Feb 6, 2025 8:30 AM
VAYK Project $700K 2024 Revenue with $150K Net Profit • VAYK • Feb 5, 2025 12:43 PM
UAV Corp (UMAV) Kicks Off Landmark "SKY" Hangar Project with Land Clearing at Costin Airport Setting Stage for Q1 2025 Groundbreaking • UMAV • Feb 5, 2025 8:30 AM
HealthLynked Corp. Releases Annual Shareholder Letter Highlighting Recent Product Development and Strategic Vision for the Future • HLYK • Feb 4, 2025 8:00 AM
Wytec Wins Multi-State Government Contract for AI Gunshot Detection • WYTC • Feb 3, 2025 7:16 AM
UAV Corp. Retains Legal Counsel to Address Legacy Debt from HTTI Era; 500 Million Authorized Shares Confirmed - UAV Corp. Delivers on Strategic Commitments • UMAV • Jan 31, 2025 1:30 PM